U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07049536) titled 'Physical Fitness of Allogeneic Stem Cell Transplant' on June 25.
Brief Summary: Hematopoietic stem cell transplantation is a treatment used to restore blood cell function in diseases of myeloid and lymphoid origin, which can be malignant or non-malignant. There are two types: autologous transplantation, which uses the patient's own stem cells, and allogeneic transplantation, which uses stem cells from a donor after a high-dose chemotherapy and radiotherapy preparation. This process can lead to complications such as immune reactions, infections, and organ toxicity, affecting the cardiovascular, musculoskeletal, and nervous systems. Th...